The exogenous administration of HGF in different animal models of fibrosis leads to less prominent or abolishes organ fibrosis in chronic kidney disease [34,35,36], unilateral ureteral obstruction [38,76], and diabetic nephropathy [40]. This evidence concerns the gene HGF and chronic kidney disease.